Cardiorespiratory Fitness, Apolipoprotein E Genotype, and Cognitive Functions: A Prospective Study

NCT ID: NCT05652140

Last Updated: 2024-11-15

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

159 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-07-01

Study Completion Date

2021-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current research project aims to investigate the interaction of cardiorespiratory fitness (CRF) and the ApoE genotype with neurocognitive functions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The current research project aims to investigate the interaction of cardiorespiratory fitness (CRF) and the ApoE genotype with neurocognitive functions. The three main purposes of the current research project seek to achieve:

1. An exploration of the associations of, as well as the interactions between, CRF assessed at the Baseline Stage, and the ApoE genotype, along with cognitive functions in cognitively healthy late-middle-aged older adults.
2. The employing of an event-related potential (ERP) to investigate the associations between the baseline CRF, the ApoE genotype, and cognitive functions in cognitively healthy late-middle-aged older adults, as well as the potential underlying neuroelectrical mechanisms.
3. An investigation of the interactions between the changes of CRFs assessed at the Baseline and the Follow-Up Stages and the ApoE genotype in relation to neurocognitive function, as well as the underlying neuroelectrical mechanisms, in cognitively healthy late-middle-aged older adults.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging Cognitive Change

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High-Risk with increased CRF

ApoE e4 carriers with increased CRF from Baseline to the Follow-Up Stages.

Data collections

Intervention Type OTHER

Data collections of cognitive function, neuroelectrical activities, ApoE genotype, and physical fitness.

High-Risk with decreased CRF

ApoE e4 carriers with decreased CRF from Baseline to the Follow-Up Stages.

Data collections

Intervention Type OTHER

Data collections of cognitive function, neuroelectrical activities, ApoE genotype, and physical fitness.

Low-Risk with increased CRF

Non-ApoE e4 carriers with increased CRF from Baseline to the Follow-Up Stages.

Data collections

Intervention Type OTHER

Data collections of cognitive function, neuroelectrical activities, ApoE genotype, and physical fitness.

Low-Risk with decreased CRF

Non-ApoE e4 carriers with decreased CRF from Baseline to the Follow-Up Stages.

Data collections

Intervention Type OTHER

Data collections of cognitive function, neuroelectrical activities, ApoE genotype, and physical fitness.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Data collections

Data collections of cognitive function, neuroelectrical activities, ApoE genotype, and physical fitness.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* right handed
* no history of cardiorespiratory disease
* normal or corrected-to-normal vision based on the 20/20 standard
* no risk of performing physical activities, as measured by the Physical Activity Readiness Questionnaire

Exclusion Criteria

* the scores of Mini-Mental Status Examination (MMSE) \< 25 and cognitively intact upon study entry
* history of psychiatric or neurological diseases
* color-blindness
Minimum Eligible Age

50 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan Normal University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yu-Kai Chang

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yu-Kai Chang, Ph.D.

Role: STUDY_DIRECTOR

Department of Physical Education and Sport Sciences, National Taiwan Normal University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Physical Education and Sport Sciences, National Taiwan Normal University

Taipei, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PACNL_APOE_PROSPECTIVE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.